V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10315548 | 10039342 | 1.69 | 66.5 | Curative (C) | 2019-10-05 | 2019-10-06 | Mitomycin Intravesical | 02 | N | MITOMYCIN INTRAVESICULAR | 100627000 |
| 10315589 | 10039343 | 1.76 | 83.8 | Palliative (P) | null | 2019-11-14 | DARATUMUMAB | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + VINCRISTINE | 100443733 |
| 10315735 | 10039345 | 1.57 | 55 | 03 | null | 2017-02-20 | CAPECITABINE + GEMCITABINE | 02 | N | CYCLOPHOSPHAMIDE + GEMCITABINE + RITUXIMAB + VINCRISTINE | 100009113 |
| 10315865 | 10039346 | 1.67 | 73.7 | Palliative (P) | 2019-09-28 | 2019-09-28 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 100425331 |
| 10315971 | 10039349 | 1.65 | 69.9 | Palliative (P) | 2018-07-12 | 2018-07-24 | Cyclophosphamide + Dex + Rituximab | N | N | CYTARABINE | 101619679 |
| 10315987 | 10039350 | null | 0 | null | 2020-01-26 | 2020-01-27 | DABRAFENIB + TRAMETINIB | null | null | SUNITINIB | 100912718 |
| 10316080 | 10039351 | 1.81 | 103.6 | null | 2018-10-16 | 2018-11-12 | Carboplatin + Vinorelbine IV | 02 | null | CARBOPLATIN + VINORELBINE | 101101748 |
| 10316128 | 10039352 | 1.62 | 70.6 | Curative (C) | 2019-09-10 | 2019-09-26 | Carboplatin + Vinorelbine Oral | 02 | N | CARBOPLATIN + VINORELBINE | 100810380 |
| 10316153 | 10039353 | 1.65 | 76 | null | 2019-12-03 | 2019-12-03 | FLUOROURACIL | 02 | N | FLUOROURACIL | 101366414 |
| 10316178 | 10039354 | 1.71 | 61 | Palliative (P) | 2017-08-06 | 2017-08-09 | Fluorouracil + Folinic Acid Weekly | 02 | null | FLUOROURACIL | 101198062 |
| 10316191 | 10039355 | 1.63 | 81.7 | Neo-adjuvant (N) | 2021-05-10 | 2021-06-12 | EOX | null | N | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | 100851709 |
| 10316240 | 10039356 | 1.52 | 81 | 03 | 2018-06-05 | 2018-08-07 | Mitomycin Intravesical | 02 | N | MITOMYCIN INTRAVESICULAR | 100368100 |
| 10316251 | 10039357 | 1.75 | 89.3 | Curative (C) | 2017-07-19 | 2017-09-12 | EOX | 02 | N | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | 100041577 |
| 10316263 | 10039358 | null | 89.7 | Adjuvant (A) | 2020-12-30 | 2021-01-11 | Acalabrutinib | 02 | N | ACALABRUTINIB | 101081584 |
| 10316313 | 10039361 | 1.46 | 88.8 | Neo-adjuvant (N) | 2017-04-13 | 2019-02-08 | IPILIMUMAB + NIVOLUMAB | 02 | N | IPILIMUMAB + NIVOLUMAB | 101604520 |
| 10316346 | 10039362 | 1.7 | 63.7 | Curative (C) | 2017-01-24 | 2017-01-26 | CLADRIBINE | 02 | N | VENETOCLAX | 100122938 |
| 10316475 | 10039363 | 1.8 | 59 | Palliative (P) | 2019-01-31 | 2019-03-02 | Cytarabine low (10to20mg/m2) IV/SC | 02 | N | MITOMYCIN | 100351272 |
| 10316494 | 10039364 | 1.65 | 78 | null | 2019-06-17 | 2019-07-19 | Avelumab | 99 | null | AVELUMAB | 101624604 |
| 10316550 | 10039366 | 1.76 | 55 | Curative (C) | 2017-12-14 | 2017-12-23 | R GCVP | 02 | N | CYCLOPHOSPHAMIDE + RITUXIMAB | 101242205 |
| 10316620 | 10039367 | 1.55 | 51.6 | Curative (C) | 2016-02-18 | 2016-03-03 | null | 02 | Y | BCG | 101014406 |
| 10316724 | 10039368 | 1.51 | 86.4 | null | 2021-05-23 | 2021-05-23 | CHOP - 21 days | 02 | null | MITOMYCIN | 101475330 |
| 10316745 | 10039370 | 0 | 83.4 | Palliative (P) | 2019-11-14 | 2019-11-14 | CHOP R - 21 days | 02 | N | CHOP R | 100383332 |
| 10316788 | 10039371 | null | 72 | Curative (C) | 2018-10-20 | 2018-11-02 | null | 02 | N | CISPLATIN + FLUOROURACIL | 100370861 |
| 10316790 | 10039372 | 1.7 | 94.6 | Palliative (P) | 2019-01-01 | 2019-01-10 | Busulfan Oral | 01 | N | CYCLOPHOSPHAMIDE + THALIDOMIDE | 101806771 |
| 10316928 | 10039374 | null | null | Adjuvant (A) | 2018-09-27 | 2018-10-24 | null | 02 | N | DABRAFENIB + TRAMETINIB | 100487981 |
| 10317030 | 10039377 | 1.74 | 59.35 | null | 2019-12-20 | 2019-12-20 | Bortezomib +/- Dexamethasone | 02 | null | BORTEZOMIB | 100690382 |
| 10317139 | 10039381 | 0.9 | 63.1 | null | 2020-06-06 | 2020-06-06 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN | N | null | FLUOROURACIL + IRINOTECAN + OXALIPLATIN | 100392226 |
| 10317170 | 10039383 | 1.68 | null | Palliative (P) | 2018-12-20 | 2019-12-11 | CHOP R | 02 | N | CHOP R | 101516160 |
| 10317183 | 10039384 | 1.52 | 68 | Palliative (P) | 2021-11-28 | 2021-12-10 | DOCETAXEL + FLUOROURACIL + OXALIPLATIN | 02 | N | DOCETAXEL + FLUOROURACIL + OXALIPLATIN | 101831055 |
| 10317188 | 10039385 | 1.8 | 89.6 | Adjuvant (A) | 2020-06-24 | 2020-06-24 | Mitomycin Intravesical | 02 | N | MITOMYCIN INTRAVESICULAR | 101515557 |
| 10317191 | 10039386 | 0 | 54.6 | null | 2019-05-25 | 2019-06-23 | Fluorouracil + Folinic Acid Weekly | null | null | FLUOROURACIL | 100194760 |
| 10317253 | 10039387 | null | null | 03 | 2018-03-20 | 2018-04-03 | BUSULFAN | 02 | N | CLADRIBINE | 100396712 |
| 10317290 | 10039388 | 1.57 | 58.6 | Neo-adjuvant (N) | 2020-12-19 | 2021-01-01 | Mitomycin Intravesical | 02 | N | MITOMYCIN INTRAVESICULAR | 100306339 |
| 10317313 | 10039389 | 1.77 | 71.3 | Curative (C) | 2017-11-22 | 2017-11-23 | DOCETAXEL + FLUOROURACIL + OXALIPLATIN | 02 | N | DOCETAXEL + FLUOROURACIL + OXALIPLATIN | 101552979 |
| 10317389 | 10039391 | null | 83.4 | Adjuvant (A) | 2017-05-31 | 2017-06-12 | CTD Attenuated (Thalidomide 100mg) | 02 | null | DABRAFENIB + TRAMETINIB | 101155384 |
| 10317405 | 10039392 | 1.72 | 80 | Curative (C) | 2002-08-30 | 2019-11-13 | CISPLATIN + VINORELBINE | 02 | N | DABRAFENIB + TRAMETINIB | 100968506 |
| 10317420 | 10039393 | 1.81 | null | null | 2018-09-08 | 2018-09-12 | FLUOROURACIL | 02 | null | FLUOROURACIL | 100710372 |
| 10317488 | 10039396 | 1.65 | 75.7 | Adjuvant (A) | 2019-02-28 | 2019-03-06 | CHOP - 21 days | 02 | N | PAZOPANIB | 100382314 |
| 10317502 | 10039397 | 1.55 | 67 | Disease modification (D) | 2018-07-02 | 2018-07-03 | MITOMYCIN | 02 | N | TRIAL | 101599762 |
| 10317587 | 10039398 | 1.65 | 59.8 | 03 | null | 2020-03-15 | CARBOPLATIN + VINORELBINE | 02 | N | CARBOPLATIN + VINORELBINE | 100106289 |
| 10317626 | 10039400 | 1.66 | 56.9 | Neo-adjuvant (N) | 2017-12-26 | 2018-02-12 | Busulfan Oral | 02 | N | CYCLOPHOSPHAMIDE + THALIDOMIDE | 100252363 |
| 10317678 | 10039401 | 1.66 | 69.8 | Palliative (P) | 2016-03-19 | 2016-03-19 | MITOMYCIN | 02 | N | BCG | 100739045 |
| 10317699 | 10039403 | 1.55 | 58 | Palliative (P) | 2018-09-23 | 2018-09-23 | Carboplatin + Vinorelbine Oral | 02 | N | CARBOPLATIN + VINORELBINE | 101176527 |
| 10317826 | 10039404 | 1.73 | 79.2 | Palliative (P) | 2019-11-28 | 2019-11-28 | Acalabrutinib | 02 | N | ACALABRUTINIB | 101182847 |
| 10317900 | 10039406 | 1.8 | 70.3 | 03 | 2019-10-30 | 2019-10-30 | Bortezomib +/- Dexamethasone | null | N | BORTEZOMIB | 101030095 |
| 10317908 | 10039407 | 1.75 | 74.8 | Curative (C) | 2019-06-09 | 2019-06-10 | EOX | 02 | N | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | 101360368 |
| 10317929 | 10039408 | null | 0 | Curative (C) | null | 2021-12-17 | MITOMYCIN | 02 | N | TRIAL | 100392420 |
| 10317936 | 10039409 | 1.8 | 63.7 | null | 2018-09-22 | 2018-10-07 | R Chlorambucil | 02 | N | CHLORAMBUCIL + RITUXIMAB | 101239262 |
| 10317972 | 10039410 | 1.79 | 101 | Curative (C) | 2021-04-18 | 2021-04-26 | POMALIDOMIDE | 02 | N | PAZOPANIB | 100482761 |
| 10318041 | 10039411 | null | 0 | null | 2020-06-18 | 2020-06-19 | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | 02 | null | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | 100796850 |